Brief: Cue Biopharma Appoints New CEO, Shifts Focus to Autoimmune Therapies
29/09/2025 14:13
Sept 29 (Reuters) - Cue Biopharma Inc CUE.O: CUE BIOPHARMA ANNOUNCES STRATEGIC TRANSITION IN LEADERSHIP TO FURTHER ENABLE NEXT STAGE OF GROWTH WITH DISRUPTIVE AUTOIMMUNE THERAPEUTIC CANDIDATES CUE BIOPHARMA INC - USMAN AZAM APPOINTED CEO OF CUE BIOPHARMA CUE BIOPHARMA INC - DANIEL PASSERI TRANSITIONS TO STRATEGIC ADVISOR AT CO Source text: ID:nGNX7tqC0T Further company coverage: CUE.O ((Reuters.Briefs@thomsonreuters.com;))